Reno, NV, November 14, 2023 — Crucial Data Solutions (CDS), the only SaaS platform to empower customer-driven global clinical trials for web and mobile environments, and nmible, a provider of cost effective clinical trial payment solutions, announced today they have formed a strategic partnership. Delivering accurate, timely payments to clinical trial participants is a common pain point in the life sciences industry that is solved by integrating CDS’ TrialKit platform with nmible’s participant reimbursement software.
nmible is now integrated directly with TrialKit, allowing researchers to automatically and securely issue reimbursements within the TrialKit platform as participants comply with required data submission activities for the study. This ensures participants receive the correct reimbursement every time they complete the necessary tasks, such as when site staff complete the relevant eCRFs as study participants visit their site or when a daily diary is completed remotely by a study participant through TrialKit’s ePRO module.
“At nmible, our mission is to alleviate the financial burden associated with clinical trial participation. Our integration with TrialKit gets us closer to that goal. By combining fast, versatile payouts with TrialKit’s platform, we are removing administrative obstacles for both patients and site staff,” said John Oxton-King, Head of Product. “This convenience and speed will make participating in trials more feasible for many by reducing out-of-pocket costs and offering payment methods to suit each patient’s needs. As we scale our global payment infrastructure through collaborations like this, our ability to ease the financial strain of trial involvement grows. We are excited to work with Crucial Data Solutions and their TrialKit platform to create a more patient-focused clinical research ecosystem where finances are never an impediment to accessing new treatments.”
“As clinical trials continue to grow in size and complexity, CDS is proud to collaborate with nmible to offer a solution that meets the industry need for a streamlined, user-friendly approach to patient reimbursement that is triggered as soon as a form/survey is completed, whether at the site by site personnel, or remotely by the study participant themselves,” said Jeff Rogers, President at CDS. “This partnership represents a significant step forward in simplifying the reimbursement process, expanding clinical trial access to a wider, more diverse pool of participants, and ultimately enhancing the overall clinical research experience for all involved.”
To learn more about the nmible integration with TrialKit, contact CDS: https://crucialdatasolutions.com/contact-us/.
About Crucial Data Solutions
Founded in 2010, Crucial Data Solutions (CDS) provides the most innovative data collection and clinical trial management technology on the market today. TrialKit, our cloud-based platform available via both a web and native mobile app, enables end-to-end trial management for medical device, diagnostics, digital therapeutics, and biotechnology companies of all sizes. Design and deploy validated studies in days not weeks using our intuitive study builder that requires no programming. Thousands of global users have leveraged the flexibility of TrialKit to deploy over 8,000 studies across all phases of development. Learn more at https://www.crucialdatasolutions.com/
At nmible we build innovative expense reimbursement software applications to provide equitable access to clinical trials. We reduce the financial burden of participation with fast, flexible cross-border expense and stipend payments, while also supporting hospital sites by reducing the administrative toil of expense processing. We are technology and automation-focused, and our integration capabilities can power all research apps and services with global payment infrastructure.
Director of Marketing
Crucial Data Solutions